Dengue infection ranges from mild fever to life-threatening hemorrhagic shock, yet there is still no dedicated antiviral treatment, and vaccine use remains limited. Early diagnosis and accurate prediction of disease progression are paramount to improving patient outcomes. However, no reliable biomarkers for severe dengue have been identified to date. To address this gap, the Eijkman… Continue reading International Partnership to Identify Biomarkers of Severe Dengue